Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis

Recently, bacterial infection causing periodontal disease has attracted considerable attention as a risk factor for pancreatic cancer. Fusobacterium species is an oral bacterial group of the human microbiome. Some evidence suggests that Fusobacterium species promote colorectal cancer development; however, no previous studies have reported the association between Fusobacterium species and pancreatic cancer. Therefore, we examined whether Fusobacterium species exist in pancreatic cancer tissue. Using a database of 283 patients with pancreatic ductal adenocarcinoma (PDAC), we tested cancer tissue specimens for Fusobacterium species. We also tested the specimens for KRAS, NRAS, BRAF and PIK3CA mutations and measured microRNA-21 and microRNA-31. In addition, we assessed epigenetic alterations, including CpG island methylator phenotype (CIMP). Our data showed an 8.8% detection rate of Fusobacterium species in pancreatic cancers; however, tumor Fusobacterium status was not associated with any clinical and molecular features. In contrast, in multivariate Cox regression analysis, compared with the Fusobacterium species-negative group, we observed significantly higher cancer-specific mortality rates in the positive group (p = 0.023). In conclusion, Fusobacterium species were detected in pancreatic cancer tissue. Tumor Fusobacterium species status is independently associated with a worse prognosis of pancreatic cancer, suggesting that Fusobacterium species may be a prognostic biomarker of pancreatic cancer.

[1]  M. Toyota,et al.  Fusobacterium in colonic flora and molecular features of colorectal carcinoma. , 2014, Cancer research.

[2]  H. Risch.  Pancreatic cancer: Helicobacter pylori colonization, N‐Nitrosamine exposures, and ABO blood group , 2012, Molecular carcinogenesis.

[3]  R. Hayes,et al.  Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. , 2012, Carcinogenesis.

[4]  Kun Wang,et al.  The serum miR‐21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR‐21 expression confers chemoresistance by targeting FasL , 2013, Molecular oncology.

[5]  A. Schetter,et al.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. , 2010, Carcinogenesis.

[6]  Hiromu Suzuki,et al.  Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway. , 2014, Carcinogenesis.

[7]  D. Michaud.  Role of bacterial infections in pancreatic cancer. , 2013, Carcinogenesis.

[8]  M. Copetti,et al.  Changes in miR-143 and miR-21 Expression and Clinicopathological Correlations in Pancreatic Cancers , 2012, Pancreas.

[9]  S. Hassenbusch,et al.  Fusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis. , 2003, Journal of neurosurgery.

[10]  Tarah Lynch,et al.  Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host , 2011, Inflammatory bowel diseases.

[11]  I. Brook,et al.  Microbiological analysis of pancreatic abscess. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  F. Moody,et al.  Mechanisms of sepsis in acute pancreatitis in opossums. , 1995, American journal of surgery.

[13]  Lin Zheng,et al.  Gastrointestinal Variant of Lemierre Syndrome: Fusobacterium nucleatum Bacteremia-Associated Hepatic Vein Thrombosis: a Case Report and Literature Review. , 2016, American journal of therapeutics.

[14]  Martin J Blaser,et al.  Bacterial biota in the human distal esophagus , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Goto,et al.  Seroprevalence of Fusobacterium varium in ulcerative colitis patients in Japan. , 2009, FEMS immunology and medical microbiology.

[16]  Nita Ahuja,et al.  The CpG island methylator phenotype: what's in a name? , 2013, Cancer research.

[17]  T. Honda,et al.  Porphyromonas gingivalis lipopolysaccharide induces miR-146a without altering the production of inflammatory cytokines. , 2012, Biochemical and biophysical research communications.

[18]  E. Giovannucci,et al.  A prospective study of periodontal disease and pancreatic cancer in US male health professionals. , 2006, Journal of the National Cancer Institute.

[19]  M. Weizenegger,et al.  Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum , 2009, Gut.

[20]  B. Birren,et al.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.

[21]  T. Ohkusa,et al.  Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis , 2003, Gut.

[22]  M. Ebert,et al.  Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[23]  N. Khardori,et al.  Fusobacterium necrophorum – beyond Lemierres syndrome , 2011, BMJ Case Reports.

[24]  M. Gazouli,et al.  Expression of MicroRNAs in Patients With Pancreatic Cancer and Its Prognostic Significance , 2013, Pancreas.

[25]  L. Tran,et al.  Endoscopically Acquired Pancreatic Cyst Fluid MicroRNA 21 and 221 Are Associated With Invasive Cancer , 2013, The American Journal of Gastroenterology.

[26]  Wei Gong,et al.  Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance , 2013, Journal of experimental & clinical cancer research : CR.

[27]  Hiromu Suzuki,et al.  MicroRNA‐31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions , 2014, International journal of cancer.

[28]  C. Croce,et al.  Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells. , 2013, The Journal of surgical research.

[29]  Shuji Ogino,et al.  NRAS Mutations Are Rare in Colorectal Cancer , 2010, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[30]  Li Zhou,et al.  Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells. , 2011, Archives of medical research.

[31]  Richard A. Moore,et al.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.

[32]  F. Clavel-Chapelon,et al.  Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study , 2012, Gut.

[33]  N. Athavale,et al.  Liver Abscesses due to Fusobacterium spp. that Mimick Malignant Metastatic Liver Disease , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[34]  M. Meyerson,et al.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.

[35]  C. Roques,et al.  Fusobacterium nucleatum in periodontal health and disease. , 2011, Current issues in molecular biology.

[36]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[37]  A. Maitra,et al.  Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth , 2014, Oncotarget.

[38]  F. C. Gibson,et al.  Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. , 2010, Molecular oral microbiology.

[39]  F. Avilés-Jiménez,et al.  Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer , 2014, Scientific Reports.

[40]  E. Giovannetti,et al.  A microRNA meta-signature for pancreatic ductal adenocarcinoma , 2014, Expert review of molecular diagnostics.

[41]  Fedor V. Karginov,et al.  Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. , 2009, Genes & development.

[42]  R H Hruban,et al.  Hypermethylation of multiple genes in pancreatic adenocarcinoma. , 2000, Cancer research.

[43]  W. Sauerbrei,et al.  Reporting recommendations for tumor marker prognostic studies (REMARK). , 2005, Journal of the National Cancer Institute.

[44]  P. Savelkoul,et al.  Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. , 2005, FEMS immunology and medical microbiology.

[45]  D. Chia,et al.  Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer , 2011, Gut.

[46]  Hong Wang,et al.  MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling , 2012, Journal of Hematology & Oncology.

[47]  Murali M. Yallapu,et al.  MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer , 2014, Oncotarget.

[48]  I. Tohnai,et al.  Liver abscess caused by periodontal bacterial infection with Fusobacterium necrophorum , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[49]  A. Uchiyama,et al.  Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma , 2012, Modern Pathology.

[50]  M. Büchler,et al.  Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon. , 2010, American journal of surgery.